BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 27190180)

  • 1. VAR2CSA Domain-Specific Analysis of Naturally Acquired Functional Antibodies to Plasmodium falciparum Placental Malaria.
    Doritchamou JY; Herrera R; Aebig JA; Morrison R; Nguyen V; Reiter K; Shimp RL; MacDonald NJ; Narum DL; Fried M; Duffy PE
    J Infect Dis; 2016 Aug; 214(4):577-86. PubMed ID: 27190180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A single full-length VAR2CSA ectodomain variant purifies broadly neutralizing antibodies against placental malaria isolates.
    Doritchamou JYA; Renn JP; Jenkins B; Mahamar A; Dicko A; Fried M; Duffy PE
    Elife; 2022 Feb; 11():. PubMed ID: 35103596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies to Escherichia coli-expressed C-terminal domains of Plasmodium falciparum variant surface antigen 2-chondroitin sulfate A (VAR2CSA) inhibit binding of CSA-adherent parasites to placental tissue.
    Saveria T; Oleinikov AV; Wiliamson K; Chaturvedi R; Lograsso J; Keitany GJ; Fried M; Duffy P
    Infect Immun; 2013 Apr; 81(4):1031-9. PubMed ID: 23319559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High levels of antibodies to multiple domains and strains of VAR2CSA correlate with the absence of placental malaria in Cameroonian women living in an area of high Plasmodium falciparum transmission.
    Tutterrow YL; Avril M; Singh K; Long CA; Leke RJ; Sama G; Salanti A; Smith JD; Leke RG; Taylor DW
    Infect Immun; 2012 Apr; 80(4):1479-90. PubMed ID: 22331427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential induction of functional IgG using the Plasmodium falciparum placental malaria vaccine candidate VAR2CSA.
    Pinto VV; Ditlev SB; Jensen KE; Resende M; Dahlbäck M; Andersen G; Andersen P; Theander TG; Salanti A; Nielsen MA
    PLoS One; 2011 Mar; 6(3):e17942. PubMed ID: 21464946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Var2CSA DBL6-epsilon domain expressed in HEK293 induces limited cross-reactive and blocking antibodies to CSA binding parasites.
    Fernandez P; Viebig NK; Dechavanne S; Lépolard C; Gysin J; Scherf A; Gamain B
    Malar J; 2008 Sep; 7():170. PubMed ID: 18771584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibodies to Cryptic Epitopes in Distant Homologues Underpin a Mechanism of Heterologous Immunity between
    Mitran CJ; Mena A; Gnidehou S; Banman S; Arango E; Lima BAS; Lugo H; Ganesan A; Salanti A; Mbonye AK; Ntumngia F; Barakat K; Adams JH; Kano FS; Carvalho LH; Maestre AE; Good MF; Yanow SK
    mBio; 2019 Oct; 10(5):. PubMed ID: 31594821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for globally shared, cross-reacting polymorphic epitopes in the pregnancy-associated malaria vaccine candidate VAR2CSA.
    Avril M; Kulasekara BR; Gose SO; Rowe C; Dahlbäck M; Duffy PE; Fried M; Salanti A; Misher L; Narum DL; Smith JD
    Infect Immun; 2008 Apr; 76(4):1791-800. PubMed ID: 18250177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of strain-transcendent antibodies to placental-type isolates with VAR2CSA DBL3 or DBL5 recombinant proteins.
    Avril M; Cartwright MM; Hathaway MJ; Smith JD
    Malar J; 2011 Feb; 10():36. PubMed ID: 21314945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of Id1-DBL2X of VAR2CSA as a key domain inducing highly inhibitory and cross-reactive antibodies.
    Bordbar B; Tuikue-Ndam N; Bigey P; Doritchamou J; Scherman D; Deloron P
    Vaccine; 2012 Feb; 30(7):1343-8. PubMed ID: 22226864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The antibody response of pregnant Cameroonian women to VAR2CSA ID1-ID2a, a small recombinant protein containing the CSA-binding site.
    Babakhanyan A; Leke RG; Salanti A; Bobbili N; Gwanmesia P; Leke RJ; Quakyi IA; Chen JJ; Taylor DW
    PLoS One; 2014; 9(2):e88173. PubMed ID: 24505415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The NTS-DBL2X region of VAR2CSA induces cross-reactive antibodies that inhibit adhesion of several Plasmodium falciparum isolates to chondroitin sulfate A.
    Bigey P; Gnidehou S; Doritchamou J; Quiviger M; Viwami F; Couturier A; Salanti A; Nielsen MA; Scherman D; Deloron P; Tuikue Ndam N
    J Infect Dis; 2011 Oct; 204(7):1125-33. PubMed ID: 21881129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Designing a VAR2CSA-based vaccine to prevent placental malaria.
    Fried M; Duffy PE
    Vaccine; 2015 Dec; 33(52):7483-8. PubMed ID: 26469717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody responses to the full-length VAR2CSA and its DBL domains in Cameroonian children and teenagers.
    Fodjo BA; Atemnkeng N; Esemu L; Yuosembom EK; Quakyi IA; Tchinda VH; Smith J; Salanti A; Bigoga J; Taylor DW; Leke RG; Babakhanyan A
    Malar J; 2016 Nov; 15(1):532. PubMed ID: 27814765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multilaboratory approach to preclinical evaluation of vaccine immunogens for placental malaria.
    Fried M; Avril M; Chaturvedi R; Fernandez P; Lograsso J; Narum D; Nielsen MA; Oleinikov AV; Resende M; Salanti A; Saveria T; Williamson K; Dicko A; Scherf A; Smith JD; Theander TG; Duffy PE
    Infect Immun; 2013 Feb; 81(2):487-95. PubMed ID: 23208604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating antibody functional activity and strain-specificity of vaccine candidates for malaria in pregnancy using in vitro phagocytosis assays.
    Hommel M; Chan JA; Umbers AJ; Langer C; Rogerson SJ; Smith JD; Beeson JG
    Parasit Vectors; 2018 Jan; 11(1):69. PubMed ID: 29378634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity of Duffy binding-like domains that bind chondroitin sulfate A and protection against pregnancy-associated malaria.
    Bir N; Yazdani SS; Avril M; Layez C; Gysin J; Chitnis CE
    Infect Immun; 2006 Oct; 74(10):5955-63. PubMed ID: 16988275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-Species Immune Recognition Between Plasmodium vivax Duffy Binding Protein Antibodies and the Plasmodium falciparum Surface Antigen VAR2CSA.
    Gnidehou S; Mitran CJ; Arango E; Banman S; Mena A; Medawar E; Lima BAS; Doritchamou J; Rajwani J; Jin A; Gavina K; Ntumngia F; Duffy P; Narum D; Ndam NT; Nielsen MA; Salanti A; Kano FS; Carvalho LH; Adams JH; Maestre A; Good MF; Yanow SK
    J Infect Dis; 2019 Jan; 219(1):110-120. PubMed ID: 30534974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chondroitin sulfate A-adhering Plasmodium falciparum-infected erythrocytes express functionally important antibody epitopes shared by multiple variants.
    Barfod L; Dobrilovic T; Magistrado P; Khunrae P; Viwami F; Bruun J; Dahlbäck M; Bernasconi NL; Fried M; John D; Duffy PE; Salanti A; Lanzavecchia A; Lim CT; Ndam NT; Higgins MK; Hviid L
    J Immunol; 2010 Dec; 185(12):7553-61. PubMed ID: 21078904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunization with recombinant duffy binding-like-gamma3 induces pan-reactive and adhesion-blocking antibodies against placental chondroitin sulfate A-binding Plasmodium falciparum parasites.
    Costa FT; Fusaï T; Parzy D; Sterkers Y; Torrentino M; Douki JB; Traoré B; Petres S; Scherf A; Gysin J
    J Infect Dis; 2003 Jul; 188(1):153-64. PubMed ID: 12825185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.